Platform Technology Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Sell
5,665
-431
-7% -$38.5K 0.1% 167
2026
Q1
$438K Buy
6,096
+1,952
+47% +$150K 0.08% 178
2025
Q4
$329K Buy
4,144
+120
+3% +$9.46K 0.07% 196
2025
Q3
$303K Sell
4,024
-248
-6% -$17K 0.07% 194
2025
Q2
$295K Buy
+4,272
New +$280K 0.08% 197
2023
Q4
Sell
-2,967
Closed -$207K 210
2023
Q3
$207K Sell
2,967
-438
-13% -$31K 0.1% 175
2023
Q2
$243K Buy
3,405
+26
+0.8% +$1.85K 0.11% 165
2023
Q1
$251K Sell
3,379
-42
-1% -$3.52K 0.12% 160
2022
Q4
$319K Sell
3,421
-48
-1% -$4.63K 0.16% 135
2022
Q3
$331K Buy
+3,469
New +$343K 0.19% 122
2022
Q2
Sell
-2,240
Closed -$227K 206
2022
Q1
$227K Sell
2,240
-87
-4% -$9.14K 0.11% 166
2021
Q4
$240K Sell
2,327
-198
-8% -$18.3K 0.11% 174
2021
Q3
$214K Sell
2,525
-246
-9% -$20.6K 0.1% 193
2021
Q2
$231K Buy
+2,771
New +$227K 0.1% 214
2020
Q4
$273K Sell
3,991
-674
-14% -$43.8K 0.13% 164
2020
Q3
$272K Buy
+4,665
New +$290K 0.17% 139

Other funds holding CVS

Platform Technology Partners's CVS Position: Q2 2026 in Review

Platform Technology Partners reduced its CVS Health (CVS) stake by 7.1% in Q2 2026, selling an estimated $38.5K and leaving 5,665 shares worth $586K. The position accounts for 0.1% of the portfolio, ranked #167.

Platform Technology Partners first reported a position in CVS in Q3 2020 and has held it in 16 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Platform Technology Partners held 5,665 shares of CVS Health worth $586K as of Q2 2026.
  • Platform Technology Partners sold 431 CVS Health shares in Q2 2026, an estimated $38.5K.
  • CVS Health made up 0.1% of Platform Technology Partners's portfolio in Q2 2026, its #167 holding.
  • Platform Technology Partners first reported a position in CVS Health in Q3 2020 and has held it in 16 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.